Ann Intern Med. 2020 Jul 16:M20-5041. doi: 10.7326/M20-5041. Online ahead of print.
ABSTRACT
In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.
PMID:32673059 | PMC:PMC7384271 | DOI:10.7326/M20-5041